Mass General Brigham Research

Annals Study Finds GLP-1s Cost-Effective for Knee Osteoarthritis, With Tirzepatide Beating Semaglutide

A validated osteoarthritis microsimulation translates trial-based weight loss into lifetime value estimates to guide payer coverage.